IONS
IONS
NASDAQ · Biotechnology

Ionis Pharmaceuticals Inc

$76.52
+0.53 (+0.70%)
As of Jun 24, 9:43 PM ET ·
Analyst Consensus
Strong Buy
33
Analysts
Very High
Coverage
Buy 27 82%
Hold 6 18%
Sell 0 0%
Price Target
Analyst Price Target -2.1% upside
Low Target $58.43
Average Target $74.94
High Target $113.95
Current Price $76.52
Current
$76.52
Target
$74.94
$58.43 $74.94 avg $113.95
Scenario Analysis
Bear Case
$58.43
-23.6%
Low target
Base Case
$74.94
-2.1%
Avg target
Bull Case
$113.95
+48.9%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$86.74
-11.8% from high
52-Week Low
$36.11
+111.9% from low
50-Day SMA
$80.92
-5.4% vs SMA
200-Day SMA
$60.03
+27.5% vs SMA
RSI (14)
47.8
Neutral
Target vs 52W High
$74.94
-13.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
Hold 44 50% $190.87 -45.7%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +189.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -7.8%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -65.2%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -32.8%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -45.0%